News

Greater Bay Area International Clinical Trial Institute (GBAICTI) was featured in the Hong Kong Pharmacy Conference 2025, held on February 22-23, 2025. Held under the theme "Embracing Innovation, Leading Paradigm Shifts, Building the Future," the conference was a pivotal annual event for the local pharmacy profession, serving as a catalyst for discussing emerging trends and shaping the future of pharmacy.

Professor Bernard Cheung, CEO of GBAICTI, delivered an insightful theme speech titled, "Enhancing Clinical Trial Capacity in Hong Kong and the Greater Bay Area: The Role of GBAICTI." His address detailed the crucial work of the institute in fostering a collaborative ecosystem for clinical research. He shared how GBAICTI was streamlining processes to connect and support academic institutions, hospitals, and pharmaceutical partners, thereby accelerating the development of innovative medicines and reinforcing Hong Kong's position as a leading hub for clinical trials.